Andre Fattori

Summary

Affiliation: Universidade Estadual de Campinas
Country: Brazil

Publications

  1. ncbi request reprint Acute myocardial infarction in sickle cell disease: a possible complication of hydroxyurea treatment
    Andre Fattori
    Hemocentro da UNICAMP, Campinas, Brazil
    Hematol J 5:589-90. 2005
  2. ncbi request reprint Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea
    Nicola Conran
    The Hematology and Hemotherapy Center, State University of Campinas UNICAMP, Campinas, Brazil
    Am J Hematol 76:343-7. 2004
  3. ncbi request reprint Gene expression profiles of erythroid precursors characterise several mechanisms of the action of hydroxycarbamide in sickle cell anaemia
    Flávia Chagas Costa
    The Haematology and Haemotherapy Centre, Faculty of Medical Sciences, State University of Campinas, Campinas, SP, Brazil
    Br J Haematol 136:333-42. 2007
  4. ncbi request reprint Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patients
    Nicola Conran
    The Haematology and Haemotherapy Centre, State University of Campinas UNICAMP, Campinas, Brazil
    Br J Haematol 124:547-54. 2004
  5. ncbi request reprint Systemic lupus erythematosus in patients with sickle cell disease
    Simone Appenzeller
    Rheumatology Unit, Department of Internal Medicine, State University of Campinas Faculty of Medical Sciences, Campinas, Brazil
    Clin Rheumatol 27:359-64. 2008

Collaborators

  • Nicola Conran
  • Simone Appenzeller
  • Flávia Chagas Costa
  • Dulcineia Martins de Albuquerque
  • Anderson Ferreira da Cunha
  • Tarcísio de Sousa Peres
  • Carolina Lanaro
  • Gustavo Gilson Lacerda Costa
  • Fernando Ferreira Costa
  • Tiago Ferraz Machado
  • Sara T Olala Saad
  • Sheley Gambero

Detail Information

Publications5

  1. ncbi request reprint Acute myocardial infarction in sickle cell disease: a possible complication of hydroxyurea treatment
    Andre Fattori
    Hemocentro da UNICAMP, Campinas, Brazil
    Hematol J 5:589-90. 2005
    ..Hematocrit and hemoglobin values of above 30% and 10.5 g/dl in SS patients on hydroxyurea therapy should be avoided or closely monitored...
  2. ncbi request reprint Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea
    Nicola Conran
    The Hematology and Hemotherapy Center, State University of Campinas UNICAMP, Campinas, Brazil
    Am J Hematol 76:343-7. 2004
    ..Such an event may benefit patients by reducing adhesive interactions between white cells and the endothelium...
  3. ncbi request reprint Gene expression profiles of erythroid precursors characterise several mechanisms of the action of hydroxycarbamide in sickle cell anaemia
    Flávia Chagas Costa
    The Haematology and Haemotherapy Centre, Faculty of Medical Sciences, State University of Campinas, Campinas, SP, Brazil
    Br J Haematol 136:333-42. 2007
    ..The genes involved in these mechanisms may represent potential tools for the identification of new targets for SCA therapy...
  4. ncbi request reprint Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patients
    Nicola Conran
    The Haematology and Haemotherapy Centre, State University of Campinas UNICAMP, Campinas, Brazil
    Br J Haematol 124:547-54. 2004
    ..Augmentation of cGMP levels by NO in erythroid cells may constitute a mechanism for induction of HbF and other erythrocyte functions and represent a possible therapeutic target for treatment of sickle cell disease...
  5. ncbi request reprint Systemic lupus erythematosus in patients with sickle cell disease
    Simone Appenzeller
    Rheumatology Unit, Department of Internal Medicine, State University of Campinas Faculty of Medical Sciences, Campinas, Brazil
    Clin Rheumatol 27:359-64. 2008
    ..Physicians should be alerted to the possible development of SLE in patients with SCD to not delay the diagnosis and start appropriate treatment...